This notice may be older or no longer active. Always verify on the official source.
LARTRUVO (olaratumab) recall in Canada: No confirmed clinical benefit
In plain language
This recall involves LARTRUVO (olaratumab) solution for injection sold in Canada. It's being recalled because a new study did not confirm its clinical benefit in prolonging lives. Patients currently receiving LARTRUVO should discuss their treatment with their physician.
What to do
- Discuss your treatment with your healthcare professional.
- Do not start LARTRUVO if you are a new patient, outside of an investigational setting.
- Report any side effects to Eli Lilly Canada Inc. or Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
LARTRUVO (olaratumab) solution for injection, 10 mg/mL (19 mL and 50 mL vials), intravenous infusion
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves LARTRUVO (olaratumab) solution for injection sold in Canada. It's being recalled because a new study did not confirm its clinical benefit in prolonging lives. Patients currently receiving LARTRUVO should discuss their treatment with their physician.
What should consumers do?
Discuss your treatment with your healthcare professional. Do not start LARTRUVO if you are a new patient, outside of an investigational setting. Report any side effects to Eli Lilly Canada Inc. or Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on January 30, 2019.
Is the LARTRUVO brand affected by this recall?
Yes, LARTRUVO products are affected by this recall. This recall involves LARTRUVO (olaratumab) solution for injection sold in Canada. It's being recalled because a new study did not confirm its clinical benefit in prolonging lives. Patients currently receiving LARTRUVO should discuss their treatment with their physician.